Immunotherapy has transformed cancer treatment. Here's what's in the clinical pipeline for 2025 and which trial types are recruiting.
About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.
What You Need to Know
An overview of cancer immunotherapy clinical trials in 2025 — checkpoint inhibitors, CAR-T cell therapies, tumor-infiltrating lymphocyte therapies, and bispecific antibodies.
Find recruiting trials for your condition
Search ClinicalTrials.gov in real time — matched to your profile, explained in plain English. Free, no account required.
Start Free Search →How Tidera Health Can Help
Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.
Enter your condition and location to see currently recruiting trials matched to your profile — with plain-English eligibility explanations and questions to ask the research coordinator.